Zhitong Deng

188 Shizi Street
Suzhou, 215006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

TREM2/DAP12 complex promotes proliferation and invasion of glioma cells via the PI3K-AKT signaling pathway.

TREM2/DAP12 complex promotes proliferation and invasion of glioma cells via the PI3K-AKT signaling pathway.

Journal: Folia neuropathologica

Published: December 10, 2025

Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.

Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.

Journal: Experimental brain research

Published: February 09, 2023

A supramolecular complex of hydrazide-pillar[5]arene and bisdemethoxycurcumin with potential anti-cancer activity.

A supramolecular complex of hydrazide-pillar[5]arene and bisdemethoxycurcumin with potential anti-cancer activity.

Journal: Bioorganic chemistry

Published: November 27, 2020

Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.

Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.

Journal: Biochemical and biophysical research communications

Published: August 30, 2020

BRD4 regulates self-renewal ability and tumorigenicity of glioma-initiating cells by enrichment in the Notch1 promoter region.

BRD4 regulates self-renewal ability and tumorigenicity of glioma-initiating cells by enrichment in the Notch1 promoter region.

Journal: Clinical and translational medicine

Published: June 29, 2020

Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).

Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).

Journal: Experimental cell research

Published: February 15, 2020

MGMT autoantibodies as a potential prediction of recurrence and treatment response biomarker for glioma patients.

MGMT autoantibodies as a potential prediction of recurrence and treatment response biomarker for glioma patients.

Journal: Cancer medicine

Published: April 29, 2019

Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway.

Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway.

Journal: Cancer genetics

Published: December 18, 2018

EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44.

EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44.

Journal: Journal of cellular biochemistry

Published: November 11, 2018

[Corrigendum] Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.

[Corrigendum] Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.

Journal: Oncology reports

Published: April 28, 2018

Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.

Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.

Journal: Oncology reports

Published: April 28, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026